Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity

被引:45
|
作者
Mohamed, Mohamed-Eslam F. [1 ]
Tseng, Tiffany [1 ]
Frye, Reginald E. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA
关键词
Green tea; EGCG; milk thistle; UGT1A1; estradiol glucuronidation; inhibition; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; LIQUID-CHROMATOGRAPHY; DRUG INTERACTIONS; GLUCURONIDATION; ESTRADIOL; PHARMACOKINETICS; CONJUGATION; METABOLISM; RALOXIFENE;
D O I
10.3109/00498254.2010.505669
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Commonly used herbal supplements were screened for their potential to inhibit UGT1A1 activity using human liver microsomes. Extracts screened included ginseng, echinacea, black cohosh, milk thistle, garlic, valerian, saw palmetto, and green tea epigallocatechin gallate (EGCG). Estradiol-3-O-glucuronide (E-3-G) formation was used as the index of UGT1A1 activity. 2. All herbal extracts except garlic showed inhibition of UGT1A1 activity at one or more of the three concentrations tested. A volume per dose index (VDI) was calculated to estimate the volume in which the daily dose should be diluted to obtain an IC50-equivalent concentration. EGCG, echinacea, saw palmetto, and milk thistle had VDI values >2.0L per dose unit, suggesting a higher potential for interaction. 3. Inhibition curves were constructed for EGCG, echinacea, saw palmetto, and milk thistle. IC50 values were (mean +/- SE) 7.8 +/- 0.9, 211.7 +/- 43.5, 55.2 +/- 9.2, and 30.4 +/- 6.9 mu g/ml for EGCG, echinacea, saw palmetto, and milk thistle extracts, respectively. 4. Based on our findings, inhibition of UGT1A1 by milk thistle and EGCG and to a lesser extent by echinacea and saw palmetto is plausible, particularly in the intestine where higher extract concentrations are anticipated. Further clinical studies are warranted.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 50 条
  • [31] Severe irinotecan-induced toxicity in a patient with UGT1A1*28 and UGT1A1*6 polymorphisms
    Jian-Ming Xu
    Yan Wang
    Fei-Jiao Ge
    Li Lin
    Ze-Yuan Liu
    Manish R Sharma
    World Journal of Gastroenterology, 2013, 19 (24) : 3899 - 3903
  • [32] UGT1A1 genotyping and neutropenia risk
    Vasconcelos, Alberto
    LANCET ONCOLOGY, 2007, 8 (10): : 873 - 873
  • [33] The Development of UGT1A1 and UGT1A6 in Pediatric Liver
    Miyagi, Shogo J.
    Abby, C.
    DRUG METABOLISM REVIEWS, 2009, 41 : 17 - 18
  • [34] Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer
    Lacko, Martin
    Roelofs, Hennie M. J.
    Morsche, Rene H. M. Te
    Voogd, Adri C.
    Ophuis, Michel B. Oude
    Peters, Wilbert H. M.
    Manni, Johannes J.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2815 - 2821
  • [35] Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity
    Takekuma, Yoh
    Takenaka, Toru
    Yamazaki, Koujiro
    Ueno, Kazuyuki
    Sugawara, Mitsuru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) : 2146 - 2153
  • [36] Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert ? s syndrome in Chinese Han people
    Zhang, Meng
    Wang, Hongwu
    Huang, Yuancheng
    Xu, Xin
    Liu, Wei
    Ning, Qin
    Chen, Tao
    Qi, Junying
    GENE, 2021, 781
  • [37] Polymorphisms of the UGT1A1 gene and cholelithiasis
    Chaouch, L.
    Said, Y.
    Mahjoubi, I.
    Chaabene, A. B.
    Douzi, K.
    Ouerhani, S.
    Abbes, S.
    TISSUE ANTIGENS, 2011, 77 (05): : 428 - 428
  • [38] Evolution of the activity of UGT1A1 throughout the development and adult life in a rat
    Bustamante, N
    Cantarino, MH
    Arahuetes, RM
    Cubero, FJ
    Ortiz, A
    LIFE SCIENCES, 2006, 78 (15) : 1688 - 1695
  • [39] Activity of rat UGT1A1 towards benzo[a]pyrene phenols and dihydrodiols
    Webb, L
    Miles, K
    Kessler, F
    Ritter, JK
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2006, 21 (03) : 224 - 230
  • [40] Comparison of effects of UGT1A1*6 and UGT1A1*28 on irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan Project
    Hikino, Keiko
    Ozeki, Takeshi
    Koido, Masaru
    Terao, Chikashi
    Kamatani, Yoichiro
    Murakami, Yoshinori
    Kubo, Michiaki
    Mushiroda, Taisei
    JOURNAL OF HUMAN GENETICS, 2019, 64 (12) : 1195 - 1202